Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Meryem Ktiouet Dawson, MD"'
Autor:
Bruce E. Johnson, MD, Christina S. Baik, MD, Julien Mazieres, MD, Harry J.M. Groen, MD, Barbara Melosky, MD, Jürgen Wolf, MD, Fatemeh Asad Zadeh Vosta Kolaei, PhD, Wen-Hsing Wu, MS, Stefanie Knoll, PhD, Meryem Ktiouet Dawson, MD, Adam Johns, PhD, David Planchard, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100324- (2022)
Introduction: BRAF mutations are rare in patients with NSCLC, and treatment options are limited. Dabrafenib plus trametinib (dab-tram) was approved for BRAFV600-mutated advanced NSCLC (aNSCLC), based on results from a phase 2 study (NCT01336634). Thi
Externí odkaz:
https://doaj.org/article/d127605cbc444e079ca861d9fffd5178
